Introduction: The Expanding Regulatory Landscape for Nitrosamine Impurities in Biologics The nitrosamine crisis that affected the small-molecule pharmaceutical industry between […]
Introduction: Why Nitrosamines in Transdermal Patches and Topical Formulations Require Specialized Attention Over the past several years, the pharmaceutical and
Introduction: Nitrosamine Testing Inhalation Drug Products MDI DPI Nasal Spray has become a critical focus area for pharmaceutical manufacturers after
Nitrosamine Testing for Inhalation Drug Products: MDIs, DPIs, and Nasal Sprays Read More »
Introduction Pharmaceutical companies often receive regulatory questions about nitrosamine impurities during submissions, variations, or post-approval reviews. When this happens, organizations
How to Respond to a Regulatory Query on Nitrosamine Risk Assessment Read More »
Introduction: The Nitrosamine Batch Release Testing Requirement becomes mandatory when confirmatory testing shows nitrosamine impurity levels above 10% of the
Nitrosamine Batch Release Testing: When Is Routine Testing Required? Read More »
Summary Introduction: Why Advanced Nitrosamine Purge Factor Calculation Is the Regulatory Game-Changer In today’s pharmaceutical impurity control landscape, Nitrosamine Purge
Advanced Purge Calculation Methodologies and Regulatory Acceptance Read More »
Summary (Key Takeaways) Introduction: Defining Nitrosamine Specification Setting in the Pharmaceutical Context Nitrosamine Specification Setting refers to the systematic process
Establishing Specifications for Nitrosamines in Drug Substances and Drug Products Read More »
🔹 Executive Summary Introduction: Understanding the Nitrosamine AI Limits Comparison When conducting a Nitrosamine AI limits Comparison across major regulatory
Global Regulatory Divergence: FDA vs. EMA vs. Health Canada on AI Limits Read More »
Introduction In recent years, the consequences of nitrosamine detection in drug products have become a major concern for the pharmaceutical
What Happens If Nitrosamines Are Detected in Your Drug Product? Read More »
Introduction: The Consequences of Nitrosamine Detection in Generic Medicines In recent years, the pharmaceutical industry has become increasingly concerned about
Why Nitrosamine Testing Is Mandatory for Generic Drug Developers Read More »
